Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Ruth Chia, Laura Palmer, Seth Love, Sonja Scholz*, American Genome Center

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

199 Citations (Scopus)
58 Downloads (Pure)

Abstract

The genetic basis of Lewy body dementia (LBD) is not well understood. Here, we performed whole-genome sequencing in large cohorts of LBD cases and neurologically healthy controls to study the genetic architecture of this understudied form of dementia, and to generate a resource for the scientific community. Genome-wide association analysis identified five independent risk loci, whereas genome-wide gene-aggregation tests implicated mutations in the gene GBA. Genetic risk scores demonstrate that LBD shares risk profiles and pathways with Alzheimer's disease and Parkinson's disease, providing a deeper molecular understanding of the complex genetic architecture of this age-related neurodegenerative condition.

Original languageEnglish
Pages (from-to)294-303
Number of pages10
JournalNature Genetics
Volume53
Issue number3
Early online date15 Feb 2021
DOIs
Publication statusPublished - Mar 2021

Research Groups and Themes

  • Cerebrovascular and Dementia Research Group

Fingerprint

Dive into the research topics of 'Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture'. Together they form a unique fingerprint.

Cite this